Progressive Mitral Stenosis After MitraClip Implantation in a Patient With Systemic Inflammatory Disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27449466.
- Also identified by DOI 10.1016/j.athoracsur.2015.12.050.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient at high surgical risk who was successfully treated with a MitraClip (Abbott Vascular, Menlo Park, CA) without transmitral gradient. She received corticosteroid therapy for systemic lupus erythematosus, and progressive mitral stenosis developed late after MitraClip implantation. It gradually increased and reached 23 mm Hg at 28 months after the procedure; during the same period, her dose of prednisone had to be increased owing to lupus flare. Systemic inflammatory disease has the potential to result in mitral valve inflammation and fibrosis, ultimately causing thickening of the tissue bridge and worsening of the mitral valve obstruction. Preprocedural counseling regarding durability may help in this population.
Medical subject headings
- Angioplasty
- Echocardiography, Transesophageal
- Heart Valve Prosthesis Implantation
- Mitral Valve Insufficiency
- Mitral Valve Stenosis